InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Seshadri Neervannan, Chief Operating Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 15 open-market SEC Form 4 transactions: 0 purchases worth $0 and 15 sales worth $2.2M, reported from Mar 16, 23 to Mar 20, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.0K | $66.75 | $200K |
| Mar 19, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.6K | $67.00 | $307K |
| Mar 18, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.6K | $68.71 | $248K |
| Mar 17, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.1K | $69.42 | $217K |
| Mar 4, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 8.4K | $76.67 | $641K |
| Mar 20, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 2.4K | $50.11 | $122K |
| Mar 19, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 2.5K | $47.40 | $121K |
| Mar 18, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 2.6K | $46.29 | $121K |
| Mar 18, 24 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.9K | $30.60 | $149K |
| Mar 23, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 390 | $12.15 | $5K |
| Mar 22, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 379 | $12.64 | $5K |
| Mar 21, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 372 | $12.89 | $5K |
| Mar 20, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 380 | $12.61 | $5K |
| Mar 17, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 360 | $13.28 | $5K |
| Mar 16, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 357 | $13.43 | $5K |